PK & PD of coadministration of XOR inhibitor and inosine
Pharmacokinetics and pharmacodynamics study of coadministration of either allopurinol or febuxostat and inosine Pharmacokinetics and pharmacodynamics study of coadministration of either allopurinol or febuxostata ...
Study on efficacy and safety of the simultaneous treatment with febuxostat and inosine of patients with Parkinson's disease. Study on efficacy and safety of the simultaneous treatment with febuxostatand inosine of patients wi ...
Study on efficacy and safety of the simultaneous treatment with febuxostat and inosine of patients with Parkinson's disease. - Effect of febuxostat and inosine on Parkinson's disease Study on efficacy and safety of the simultaneous treatment with febuxostatand inosine of patients wi ...
Parkinson's disease
Administration of febuxostat 20 mg and inosine 500 mg twice a day for 58 days
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. Studies of efficacy and safety of the combined use of febuxostatand inosine for patients with Alzhei ...
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. - Effect of febuxostat and inosine on CNS diseases Studies of efficacy and safety of the combined use of febuxostatand inosine for patients with Alzhei ...
Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis
Treatment with febuxostat 20 mg and inosine 0.5 g, twice a day for 2 weeks
Tsukuba International Clinical Pharmacology Clinic